Xalatan

Basic Xalatan Information

• INN (International Nonproprietary Name): Latanoprost
• Brand Names Available In United Kingdom: Xalatan; Monoprost; generic latanoprost (Glenmark, Sun Pharma) — exact UK marketing authorisations not specified in the raw data
• ATC Code: S01EE01
• Forms & Dosages: Ophthalmic solution 0.005% (0.05 mg/mL) in multidose 2.5 mL or 5 mL vials; preservative‑free single‑dose containers also available
• Manufacturers In United Kingdom: Viatris (Pfizer), Théa, Glenmark, Sun Pharma — specific UK manufacturer listings not specified in the raw data
• Registration Status In United Kingdom: Not specified in the raw data; Europe and national approvals noted for Xalatan and Monoprost
• OTC / Rx Classification: Prescription only medicine (Rx)

Market Snapshot

What should patients know about availability and choice for latanoprost?

Xalatan (latanoprost) remains the globally dominant prostaglandin analogue for open‑angle glaucoma and ocular hypertension.

Multiple brands and generics coexist, creating choice and price pressure across supply chains.

Major suppliers named in the data include Viatris (Pfizer), Théa, Glenmark and Sun Pharma.

Standard concentration is 0.005% (0.05 mg/mL), which is consistent across brands and generics.

Packaging differences and preservative‑free options drive patient preference and tolerability decisions.

Patients often ask “Can I buy Xalatan UK?” and the practical answer is that latanoprost is prescription‑only and dispensed via NHS or private routes.

Common search intents include finding Xalatan 0.005% eye drops and generic latanoprost options for ocular hypertension.

• Xalatan — 2.5 mL / 5 mL multidose
• Monoprost — single‑dose preservative‑free
• Generics (Glenmark, Sun Pharma) — 2.5 mL / 5 mL

Availability And Packaging

Patients want to know which pack will last and what format suits them best.

Latanoprost is most commonly supplied as a 0.005% ophthalmic solution in 2.5 mL or 5 mL multidose vials.

Preservative‑free single‑dose vials are available for those with sensitivity; examples include Monoprost and Iyuzeh in listed markets.

Some brands advise refrigeration before opening; after opening the typical in‑use discard window is 4–6 weeks per labelling.

Bottle design and dropper tip differ between manufacturers and affect drop size and ease of instillation.

Common packaging types from the raw data: 2.5 mL and 5 mL dropper vials, and single‑dose containers for preservative‑free solutions.

Patients who use contact lenses or have dry eye often prefer preservative‑free single‑dose units.

UK Retail Context

How do patients in the United Kingdom actually get latanoprost?

In the UK, latanoprost sits within a prescription‑only framework and is supplied via NHS prescriptions, private prescriptions and online pharmacies that accept valid prescriptions.

Practical realities include variable waiting times for repeats and regional differences in prescription charges.

Prescriptions are free in Scotland, Wales and Northern Ireland; England has exemptions for many groups.

Electronic Prescription Service (EPS) is increasingly common for repeats, reducing delays for long‑term glaucoma therapy.

Major retail channels named in the data include Boots, LloydsPharmacy and Superdrug alongside independents and certified online providers.

In our online pharmacy, xalatan is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Typical Day‑To‑Day Use

Patients often ask “When should I put my glaucoma drops in?”

Latanoprost is intended as a once‑daily eye drop, taken in the evening for most patients.

Real‑world users report that an evening routine helps adherence because dosing is simple and fits bedtime habits.

Expected clinical effect on intraocular pressure (IOP) may be noticeable within days, with full stabilisation over a few weeks.

Common practical issues include handling small bottles, accurately squeezing a single drop and remembering the dose on busy days.

Adherence can be affected by manual dexterity, vision impairment and complexity when multiple eye drops are prescribed.

Tolerability And Patient Trade‑Offs

People balance efficacy with cosmetic or local effects when choosing latanoprost brands.

Typical trade‑offs include desirable IOP control versus cosmetic changes such as eyelash growth and periocular skin darkening.

Many patients accept mild conjunctival hyperaemia or brief stinging when they understand the benefit of reduced risk of glaucoma progression.

Some choose preservative‑free options to reduce chronic ocular surface irritation at the cost of higher per‑unit price.

Pharmacy counselling helps patients weigh these tolerability issues against long‑term visual protection.

Preservative Concerns

Is preservative in the bottle causing my dry eye?

Preservative sensitivity is a recognised practical problem for some patients on chronic topical therapy.

Preservative‑free single‑dose units (Monoprost, Iyuzeh in listed markets) are increasingly used for contact lens wearers and patients with dry eye or blepharitis.

Switching to a preservative‑free option often reduces irritation, but bottle handling and in‑use discard rules still apply.

Patient Checklist

• Storage: Refrigerate before opening if the brand label instructs it.
• Dosing time: One drop once daily in the evening.
• Cosmetic effects: Expect possible eyelash growth and iris pigmentation changes.
• Preservatives: Ask for preservative‑free if you have chronic irritation.

Quick FAQ

• Q: Can I switch brands? — A: Yes, concentration remains 0.005% but bottle design and excipients differ; pharmacy can advise.
• Q: How long after opening? — A: Follow label; commonly 4–6 weeks.
• Q: Can I use with contact lenses? — A: Remove lenses before instillation and wait 15 minutes; preservative‑free is preferable.

Active Substance And ATC

What is the pharmacological identity of Xalatan?

The active substance is latanoprost, an ophthalmological prostaglandin analogue.

ATC code is S01EE01, meaning S01 (ophthalmologicals), EE (prostaglandin analogues) and 01 (latanoprost).

The product reduces intraocular pressure by increasing uveoscleral outflow.

Formulations Sold

Which formulations appear in the supply chain?

Core formulation across brands is ophthalmic solution 0.005% (0.05 mg/mL).

Multidose 2.5 mL and 5 mL dropper vials are the most common formats reported.

Preservative‑free single‑dose containers are available for those with sensitivity.

Packaging Variants

Bottle design, tip geometry and drop volume vary by manufacturer and affect patient experience.

Some brands explicitly state refrigeration before opening while others rely on patient counselling at supply.

Licensed Indications

Why has the ophthalmologist chosen this drop?

Latanoprost is licensed to reduce elevated intraocular pressure in open‑angle glaucoma and ocular hypertension.

It is the most widely prescribed first‑line prostaglandin analogue for these indications.

First‑Line Use And Positioning

Where does it sit in therapy?

Prostaglandin analogues like latanoprost are commonly prescribed first line when topical monotherapy is suitable.

They are favoured for once‑daily dosing convenience and strong IOP‑lowering effect.

Duration Of Therapy

How long will a patient use Xalatan?

Treatment is chronic and continued as long as IOP control is required and tolerated.

Patients should expect long‑term therapy and regular ophthalmology follow‑up to monitor response and adverse effects.

1. Indication: Open‑angle glaucoma or ocular hypertension.
2. First‑line: Where prostaglandin analogue appropriate.
3. Switch/referral: If intolerant or inadequate control, discuss with prescriber and consider referral.

Standard Dosing

How much and how often should the drops be used?

Standard dose is one drop of 0.005% in the affected eye(s) once daily, preferably in the evening.

Dosing more frequently does not increase efficacy and may reduce effect.

Administration Technique

Patients often ask for a step‑by‑step demonstration.

1. Wash hands and remove contact lenses if worn.
2. Tilt head back and pull down lower eyelid to form a small pocket.
3. Hold the bottle above the eye and instil a single drop, avoiding contact with the eye.
4. Close the eye gently and apply nasolacrimal occlusion for 1–2 minutes to reduce systemic absorption.
5. Wait 5–10 minutes before using another topical ophthalmic product.

Refrigeration before opening is common for many brands; after opening store below 25°C and discard after 4–6 weeks per labelling.

Missed Dose And Overdose Advice

Common patient questions about errors in dosing.

If a dose is missed, give it as soon as remembered the same day but do not double up the next dose.

In case of accidental overdose, rinse the eye with water; systemic toxicity is unlikely but seek medical help for ingestion or persistent symptoms.

Absolute Contraindications

When must latanoprost not be used?

Absolute contraindications include known hypersensitivity to latanoprost or any component of the formulation.

History of herpetic keratitis is listed as a situation needing specialist input before use.

Relative Cautions Requiring Monitoring

Which conditions need extra attention?

Active intraocular inflammation such as uveitis warrants caution and monitoring.

Aphakia or ruptured posterior lens capsule increases macular oedema risk and requires specialist oversight.

Severe asthma is a relative caution because rare bronchospasm has been reported.

Special Populations

What about children and older adults?

Paediatric data are limited; consult a specialist for under‑18 patients or complex paediatric glaucoma.

Elderly patients generally do not require dose adjustment but monitor for ocular surface disease.

Common Expected Effects

Which side effects should patients expect?

Common local effects include increased iris pigmentation, eyelash growth and periocular skin darkening.

Mild conjunctival hyperaemia and transient burning or stinging are also reported.

Moderate/Serious Reactions

Which reactions require urgent attention?

Macular oedema is uncommon but is a recognised risk in aphakic or pseudophakic eyes with posterior capsule defects.

Uveitis and marked vision changes are less common but serious and require prompt ophthalmology review.

Reassurance And When To Seek Help

How to counsel patients about side effects.

Explain that cosmetic changes such as iris pigmentation are generally permanent but not harmful.

Advise patients to seek urgent care for sudden vision changes, severe pain or marked redness.

Report suspected adverse reactions via the MHRA Yellow Card scheme and notify the prescriber for serious events.

• Keep a record of any new visual symptoms and present promptly if they occur.

Other Prostaglandin Analogues

What are the alternatives if latanoprost is unsuitable?

Competitors include bimatoprost (Lumigan), travoprost (Travatan Z) and tafluprost (Saflutan — preservative‑free).

Each has a similar mechanism but may differ in tolerability and cost.

Generics And Preservative‑Free Swaps

Can patients switch to a generic or preservative‑free product?

Generics from Glenmark, Sun Pharma and others provide cost savings while maintaining the 0.005% concentration.

Preservative‑free options such as Monoprost and Iyuzeh are alternatives for patients with sensitivity.

Switching Considerations

What should be discussed when changing product?

Confirm the same concentration (0.005%) and inform the patient about potential differences in bottle feel, drop size and temporary tolerability changes.

Coordinate with the prescriber before switching and document any prior adverse reactions.

Multidose Vs Single‑Dose Pros/Cons

Which pack size is right for the patient?

Multidose vials (2.5 mL/5 mL) are more cost‑efficient and common for long‑term therapy.

Single‑dose preservative‑free units reduce preservative exposure and contamination risk but cost more and can be less convenient to store and handle.

Cost And NHS Considerations

How do NHS prescribing rules affect selection?

NHS prescribing usually favours cost‑effective generics listed on local formularies or the Drug Tariff.

Private prescriptions or online purchases can vary in price and sometimes offer faster access to preservative‑free options.

Practical Selection Tips For Dispensing

Top pointers for pharmacy selection.

• Offer an ergonomic bottle for patients with tremor.
• Check refrigeration labelling and advise on discard interval after opening.
• Consider a preservative‑free single‑dose option for ocular surface disease.

NHS Prescribing And Reimbursement

How is latanoprost funded in the UK?

Products are prescription‑only and subject to NHS prescribing rules and local formulary choices.

Prescriptions are free in Scotland, Wales and Northern Ireland; England has charge exemptions.

Pharmacies source stock from wholesalers or direct manufacturer supply chains guided by the BNF and MHRA advice.

Private Prescriptions And Online Pharmacies

How do private routes change access and price?

Private prescriptions and certified online pharmacies can expedite access and may list preservative‑free options at varying prices.

Always ensure a valid prescription is supplied prior to dispensing.

Chain Vs Independent Pharmacy Dynamics

How do different retailers compare for patients?

Large chains may stock a wider variety and offer click‑and‑collect, while independents can be flexible with special orders and personalised counselling.

Flow Of Ordering To Supply

Ordering online or in‑store generally follows: prescriber issues prescription → pharmacy sources product → pharmacist checks and dispenses.

Manufacturer Storage Guidance

What are the cold‑chain requirements for pharmacies?

Many latanoprost brands should be stored refrigerated at 2–8°C before opening, according to the data.

After opening, store below 25°C, protect from light and discard after 4–6 weeks as per labelling.

After‑Opening Handling

How should opened stock be managed?

Once opened, multidose vials are kept at room temperature below 25°C and used within the manufacturer’s in‑use time.

Single‑dose units reduce contamination risk but should be used immediately after opening.

Stock Rotation And Recalls

Good pharmacy practice requires temperature logs and first‑expiry‑first‑out rotation.

Keep MHRA and manufacturer recall contacts readily available and label dispensed stock with clear expiry and storage advice for patients.

• Fridge logs maintained daily.
• Clear patient labelling about storage and discard interval.
• Separate storage for opened and unopened stock where possible.

Key Counselling Points To Cover

What must be said at the point of supply?

Confirm patient identity and indication and explain that latanoprost reduces high eye pressure to protect sight.

Give clear dosing instructions: one drop once daily in the evening, avoid touching the eye with the bottle tip.

Explain storage (refrigeration before opening if labelled), discard period after opening and the need for regular ophthalmology follow‑up.

Practical Tips For Instillation And Adherence

Short, practical advice improves adherence.

• Set a daily reminder at bedtime to aid once‑daily dosing.
• Use nasolacrimal occlusion to reduce systemic absorption.
• Wait 5–10 minutes between multiple eye drops.

Documentation And Follow‑Up

Record counselling in the patient medication record and offer repeat dispensing or reminder services where available.

Encourage patients to attend scheduled ophthalmology appointments for IOP checks and to report adverse effects promptly.

Immediate Actions At Pharmacy

How should staff manage adverse events presented in‑store?

For mild irritation suggest symptomatic measures and reassess; for severe pain or sudden vision loss stop the product and escalate urgently.

Assist the patient to contact ophthalmology or emergency services if vision is significantly affected.

When To Refer To Ophthalmology

Referral is required for suspected macular oedema, uveitis, unexplained vision change or severe ocular pain.

Also refer when there is suspicion of preservative allergy or when switching therapy is clinically complex.

Reporting To MHRA (Yellow Card)

Encourage patients and staff to report suspected adverse reactions via the MHRA Yellow Card system.

Pharmacists should document events, notify the prescriber and inform the manufacturer for serious reactions.

1. Minor irritation: advise symptomatic care and monitor.
2. Serious signs: stop product and refer to ophthalmology urgently.
3. Complete Yellow Card report and record details in patient record.

Mandatory Regulatory Information

What must appear on a product page or leaflet?

Display the INN (latanoprost), brand name, concentration (0.005% / 0.05 mg/mL) and prescription status clearly.

Include storage advice, discard interval, contraindications and common side effects as required by MHRA guidance.

SEO And User Experience Elements

Optimise product pages for purchase intent while remaining compliant.

Include clear calls to action for prescription upload, pharmacist contact and downloadable patient leaflets.

Use structured tables for pack comparisons and visual dosing guidance to improve conversion and safety.

Visuals, Tables And Trust Signals

Trust signals such as MHRA and manufacturer logos, verified reviews and accessible patient information leaflets increase confidence.

Provide a product comparison table, FAQ accordion and downloadable PIL to support informed purchase decisions.

Delivery Across United Kingdom

Stepwise Triage For Adverse Events

Follow a clear triage when a patient reports a reaction.

1. Assess severity: mild irritation versus sudden vision change or severe pain.
2. Mild cases: advise symptomatic care and monitor; consider preservative‑free switch if persistent.
3. Serious cases: stop product and refer urgently to ophthalmology or A&E.
4. Document details and support the patient to submit an MHRA Yellow Card report.

Yellow Card Reporting Template

Provide patients with the basic information required for a Yellow Card report.

• Patient details (initials, age, region).
• Product name and batch number if available.
• Nature of reaction, onset time and outcome.
• Contact details for follow‑up.

Point‑Of‑Sale Counselling Script

Use this concise script at supply to ensure safe use.

“This medicine is latanoprost, for reducing raised eye pressure to protect your vision.”

“Use one drop in the affected eye once every evening.”

“Avoid touching the eye with the bottle tip; refrigerate before opening if the label says so, and discard after 4–6 weeks once opened.”

“Common effects are eyelash growth and possible eye redness; seek urgent help for sudden vision changes or severe pain.”

Staff Checklist At Supply

• Confirm valid prescription and indication.
• Demonstrate instillation or provide leaflet with clear steps.
• Explain storage, discard time and contact routes for adverse events.
• Offer adherence aids and document counselling in the patient record.

Final Practical Notes For Pharmacies

Maintain cold‑chain logs, rotate stock by expiry and label dispensed medicine with patient‑facing storage/discard advice.

Ensure staff know the local referral pathway to ophthalmology and keep MHRA Yellow Card links accessible for reporting.

When in doubt about switching or complex ocular histories, liaise with the prescriber or ophthalmologist before changing therapy.